| Variables | P value | HR | 95%CI | |
---|---|---|---|---|---|
Total cohort | Â | Â | Â | Â | |
 | AF duration | 0.040 | 1.002 | 1.000 | 1.004 |
 | Hypertension | 0.120 | 1.198 | 0.954 | 1.505 |
 | LAVI | < 0.001 | 1.015 | 1.008 | 1.021 |
 | Female | 0.620 | 1.061 | 0.839 | 1.343 |
 | AF type | 0.468 | 0.907 | 0.697 | 1.181 |
 | AAD | 0.456 | 1.138 | 0.809 | 1.601 |
Paroxysmal AF | Â | Â | Â | Â | Â |
 | Female | 0.110 | 0.771 | 0.561 | 1.061 |
 | Hypertension | 0.216 | 1.215 | 0.892 | 1.655 |
 | extraPV ablation | 0.129 | 0.700 | 0.442 | 1.110 |
 | AF duration | 0.409 | 1.001 | 0.998 | 1.004 |
 | LAVI | 0.001 | 1.019 | 1.009 | 1.029 |
Persistent AF | Â | Â | Â | Â | Â |
 | Female | 0.003 | 1.686 | 1.196 | 2.377 |
 | extraPV ablation | 0.762 | 0.932 | 0.590 | 1.471 |
 | AAD | 0.691 | 0.902 | 0.542 | 1.501 |
 | AF duration | 0.037 | 1.003 | 1.000 | 1.006 |
 | LAVI | 0.016 | 1.010 | 1.002 | 1.019 |